Xuebijing Injection Combined with Antibiotics for the Treatment of Spontaneous Bacterial Peritonitis in Liver Cirrhosis: A Meta-Analysis

Abstract EN

Background and Aim.

Spontaneous bacterial peritonitis (SBP) is one of the most common complications of liver cirrhosis.

Antibiotics are the main treatment regimen of SBP.

Traditional Chinese medicine Xuebijing injection has been used in such patients.

Our study aimed to overview the efficacy of Xuebijing injection combined with antibiotics for the treatment of SBP.

Method.

We searched the PubMed, Embase, China National Knowledge Infrastructure, VIP, and Wanfang databases.

The search items included “Xuebijing”, “peritonitis”, “liver cirrhosis”, and “random” to identify all relevant randomized controlled trials (RCTs).

The Cochrane risk of bias tool was used to assess the study quality.

The odd ratios (ORs) with 95% confidence intervals (CIs) were calculated by using a random-effect model.

Heterogeneity was also calculated.

Results.

A total of 9 RCTs were included.

The study quality was unsatisfied.

The overall (OR = 2.95, 95% CI = 1.97–4.42, p<0.00001) and complete (OR = 2.18, 95% CI = 1.57–3.04, p<0.00001) responses were significantly higher in the Xuebijing injection combined with antibiotics group than the antibiotics alone group.

The incidence of cirrhosis related complications, including hepatic encephalopathy and hepatorenal syndrome, was lower in the Xuebijing injection combined with antibiotics group than the antibiotics alone group.

No significant heterogeneity was observed among studies.

Conclusion.

Additional use of Xuebijing injection may improve the efficacy of antibiotics for the treatment of SBP in liver cirrhosis.

However, due to a low level of current evidence, we did not establish any recommendation regarding the use of Xuebijing injection for the treatment of SBP.